These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23296340)

  • 21. Understanding graft-induced dyskinesia.
    Lane EL; Smith GA
    Regen Med; 2010 Sep; 5(5):787-97. PubMed ID: 20868333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease.
    Kim SU; Park IH; Kim TH; Kim KS; Choi HB; Hong SH; Bang JH; Lee MA; Joo IS; Lee CS; Kim YS
    Neuropathology; 2006 Apr; 26(2):129-40. PubMed ID: 16708545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming obstacles in Parkinson's disease.
    Sherer TB; Chowdhury S; Peabody K; Brooks DW
    Mov Disord; 2012 Nov; 27(13):1606-11. PubMed ID: 23115047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unleashing the cure: Overcoming persistent obstacles in the translation and expanded use of hematopoietic stem cell-based therapies.
    Talib S; Shepard KA
    Stem Cells Transl Med; 2020 Apr; 9(4):420-426. PubMed ID: 31957346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.
    Almeida-Porada G; Atala A; Porada CD
    Mol Ther Methods Clin Dev; 2016; 5():16020. PubMed ID: 27069953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease.
    Soler R; Füllhase C; Hanson A; Campeau L; Santos C; Andersson KE
    J Urol; 2012 Apr; 187(4):1491-7. PubMed ID: 22341818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of histocompatible primate-induced pluripotent stem cells for neural transplantation.
    Deleidi M; Hargus G; Hallett P; Osborn T; Isacson O
    Stem Cells; 2011 Jul; 29(7):1052-63. PubMed ID: 21608081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo visualization and monitoring of viable neural stem cells using noninvasive bioluminescence imaging in the 6-hydroxydopamine-induced mouse model of Parkinson disease.
    Im HJ; Hwang DW; Lee HK; Jang J; Lee S; Youn H; Jin Y; Kim SU; Kim EE; Kim YS; Lee DS
    Mol Imaging; 2013 Jun; 12(4):224-34. PubMed ID: 23651500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human embryonic stem cell therapies for neurodegenerative diseases.
    Tomaskovic-Crook E; Crook JM
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):440-8. PubMed ID: 21495960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dental pulp stem cells in MPTP-induced old-aged mice model.
    Gnanasegaran N; Govindasamy V; Simon C; Gan QF; Vincent-Chong VK; Mani V; Krishnan Selvarajan K; Subramaniam V; Musa S; Abu Kasim NH
    Eur J Clin Invest; 2017 Jun; 47(6):403-414. PubMed ID: 28369799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In utero hematopoietic stem cell transplants for inherited diseases.
    Cowan MJ; Golbus M
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):35-42. PubMed ID: 7906103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Parkinson disease hits both old and young persons. Cell transplantation to the brain is the hope of cure].
    Johnels B
    Lakartidningen; 2001 Mar; 98(13):1500-1. PubMed ID: 11330143
    [No Abstract]   [Full Text] [Related]  

  • 34. Transplantation of Neural Precursor Cells in the Treatment of Parkinson Disease: An Efficacy and Safety Analysis.
    Lige L; Zengmin T
    Turk Neurosurg; 2016; 26(3):378-83. PubMed ID: 27161464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson disease.
    Chinta SJ; Andersen JK
    Cell Cycle; 2011 Dec; 10(24):4179-80. PubMed ID: 22157187
    [No Abstract]   [Full Text] [Related]  

  • 36. [Stem cell therapy in Parkinson disease].
    Schindehütte J; Paulus W; Mansouri A
    Pharm Unserer Zeit; 2006; 35(3):250-4. PubMed ID: 16724529
    [No Abstract]   [Full Text] [Related]  

  • 37. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
    Zhang F; Pasumarthi KB
    BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental clinical transplantation in patients with Parkinson disease. Experimental background and clinical picture].
    Ostergaard K; Rasmussen JZ
    Ugeskr Laeger; 1991 Dec; 153(50):3554-8. PubMed ID: 1776197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transplantation of the superior cervical ganglion into the brain--a new experimental therapy of Parkinson disease].
    Itakura T; Kamei I; Nakai K; Nakai M; Naka Y; Nakakita K; Imai H; Komai N
    No To Shinkei; 1988 Mar; 40(3):285-90. PubMed ID: 3134931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cell therapy in Parkinson disease.
    Lindvall O; Hagell P
    Neurosurg Focus; 2002 Nov; 13(5):e2. PubMed ID: 15769071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.